A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.

NCT00637390 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped Genzyme will no longer supply the study drug for this trial as it does not believe the study will not fully enroll within an appropriate time frame.

Conditions

Interventions

Sponsor

University of Michigan Rogel Cancer Center